4.1 Article

Relapse rates with long-term antidepressant drug therapy: a meta-analysis

Journal

Publisher

WILEY
DOI: 10.1002/hup.1033

Keywords

antidepressant; long term; meta-analysis; placebo; depression; recurrence; relapse

Funding

  1. NIMH [1K08MH70615-01A1]
  2. Cyberonics, Inc.
  3. Mood Disorders Program at the Medical University of South Carolina

Ask authors/readers for more resources

Background Several long-term double-blind placebo controlled trials have shown prophylactic antidepressant therapy in unipolar depression. The goal of this work was to conduct a meta-analysis that would incorporate the most recent trials and evaluate their overall level of efficacy and relapse prevention over time. Methods We performed a comprehensive literature search. The extracted data from selected studies were used to construct a regression model and evaluate the effect of treatment, time on medication, severity of illness, age, gender, and number of previous episodes. Results Across 11 maintenance treatment studies, the relapse rate was significantly different at 1 year for active drug (23%) versus placebo (51%). In addition, time on medication significantly affected the relapse rate. Conclusion Prophylactic antidepressant drug therapy appears efficacious in preventing future relapses across a range of illness severity as well as age. More studies are needed to explore the effects of various acute antidepressant strategies and the direct influence of treatment resistance on relapse outcomes. Copyright (C) 2009 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available